Apollon Papadimitriou
Director Ejecutivo en iOmx Therapeutics AG .
Perfil
Apollon Papadimitriou is currently the Chief Executive Officer at iOmx Therapeutics AG.
He started this position in 2019.
Prior to his current role, he obtained a doctorate degree from Julius-Maximilians-Universität Würzburg in 1995.
Cargos activos de Apollon Papadimitriou
| Empresas | Cargo | Inicio |
|---|---|---|
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Director Ejecutivo | 01/07/2019 |
Formación de Apollon Papadimitriou.
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Apollon Papadimitriou
